Tetsuhito Kojima Selected Research

Tetsuhito Kojima Research Topics

Disease

20	Thrombosis (Thrombus) 01/2022 - 04/2002
10	Hemorrhage 01/2023 - 08/2002
9	Venous Thrombosis (Deep-Vein Thrombosis) 06/2018 - 02/2006
8	Thrombophilia 02/2022 - 07/2014
6	Leukemia 01/2014 - 03/2002
5	Hemophilia A (Haemophilia) 02/2021 - 08/2006
5	Inflammation (Inflammations) 10/2019 - 05/2005
4	Hemophilia B (Haemophilia B) 01/2022 - 07/2015
4	Neoplasms (Cancer) 01/2014 - 05/2004
4	Neuroblastoma 06/2012 - 09/2007
3	Venous Thromboembolism 06/2019 - 04/2002
3	Vascular System Injuries 04/2018 - 04/2004
3	Pneumonia (Pneumonitis) 02/2016 - 08/2012
3	Colonic Neoplasms (Colon Cancer) 10/2015 - 05/2004
2	Disseminated Intravascular Coagulation 01/2023 - 10/2006
2	Protein S Deficiency (Deficiency, Protein S) 02/2022 - 07/2004
2	Fibrosis (Cirrhosis) 10/2019 - 02/2004
2	Hypoxia (Hypoxemia) 10/2015 - 05/2004
2	Infections 02/2013 - 08/2012
2	Carcinogenesis 08/2012 - 09/2007
2	Breast Neoplasms (Breast Cancer) 06/2012 - 11/2009
2	Infarction (Infarctions) 05/2011 - 02/2004
2	Myocardial Infarction 05/2011 - 02/2004
2	Obesity 05/2005 - 12/2002
1	Aortic Diseases 01/2023
1	Type 3 von Willebrand Disease 01/2022
1	hereditary Thrombophilia 09/2021
1	Inherited Blood Coagulation Disorders 06/2021
1	Confusion (Bewilderment) 06/2021
1	Splenomegaly 02/2021
1	Joint Diseases (Joint Disease) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2019
1	Pulmonary Embolism 06/2018
1	Disease Susceptibility (Diathesis) 03/2016
1	Lung Diseases (Lung Disease) 02/2016
1	Bacterial Pneumonia 11/2015
1	Prostatic Neoplasms (Prostate Cancer) 10/2015
1	Autoimmune Diseases (Autoimmune Disease) 08/2014
1	Necrosis 07/2013

Drug/Important Bio-Agent (IBA)

16	AntithrombinsIBA 09/2021 - 04/2002
11	Proteins (Proteins, Gene)FDA Link 03/2016 - 12/2003
10	Syndecan-4IBA 10/2019 - 05/2002
9	Prothrombin (Factor II)IBA 06/2018 - 06/2012
8	Protein SIBA 02/2022 - 10/2007
8	Messenger RNA (mRNA)IBA 01/2022 - 02/2004
6	Protein CIBA 09/2021 - 08/2002
5	AnticoagulantsIBA 09/2021 - 01/2009
5	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 06/2006
4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 07/2015
4	von Willebrand FactorIBA 01/2022 - 04/2004
4	EnzymesIBA 10/2015 - 12/2003
4	CytokinesIBA 07/2013 - 02/2004
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2012 - 03/2002
4	Plasminogen Activator Inhibitor 1IBA 05/2005 - 11/2002
4	Plasminogen Activators (Plasminogen Activator)IBA 05/2005 - 11/2002
3	LigandsIBA 02/2013 - 03/2002
3	LipopolysaccharidesIBA 08/2012 - 04/2002
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 06/2012 - 03/2002
2	FibrinIBA 01/2023 - 08/2002
2	Dacarbazine (DIC)FDA LinkGeneric 01/2023 - 10/2006
2	Blood Coagulation Factors (Coagulation Factor)IBA 06/2021 - 03/2016
2	Arginine (L-Arginine)FDA Link 06/2018 - 06/2012
2	Transcription Factors (Transcription Factor)IBA 10/2015 - 01/2014
2	ThrombomodulinIBA 06/2015 - 08/2002
2	Thrombin FDA Link 07/2014 - 02/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 05/2004
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2014 - 11/2009
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 07/2013 - 05/2011
2	Ribavirin (Virazole)FDA LinkGeneric 02/2013 - 01/2013
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 11/2011 - 09/2007
2	Factor V (Coagulation Factor V)IBA 04/2010 - 11/2009
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2009 - 08/2002
2	sphingosine kinaseIBA 09/2007 - 12/2003
1	Tranexamic Acid (AMCA)FDA Link 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	DisulfidesIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	protein S TokushimaIBA 09/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Hemoglobins (Hemoglobin)IBA 02/2021
1	Erythropoietin FDA Link 02/2021
1	Chromogenic CompoundsIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019
1	CollagenIBA 10/2019
1	emicizumabIBA 10/2019
1	Combined Oral ContraceptivesIBA 09/2016
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Deubiquitinating EnzymesIBA 10/2015
1	Acid CeramidaseIBA 10/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2015
1	UbiquitinIBA 10/2015
1	AndrogensIBA 10/2015
1	Fibrinogen (Factor I)FDA Link 10/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2014
1	DNA Ligase ATPIBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2023 - 06/2006
1	Perioperative Period 10/2019